ProCE Banner Series

Enhancing Care and Management of Transplant Recipients: Expert Strategies for Mitigating COVID-19 Risk

Join expert faculty as they discuss how to integrate the latest scientific data and developments in COVID-19 prevention into optimized management approaches in transplant recipients.

  ACPE
  | AMA
Who Should Attend

This program is intended for transplant and infectious diseases specialists and other healthcare professionals who care for solid organ transplant recipients.

All Events

Enhancing Care and Management of Transplant Recipients: Expert Strategies for Mitigating COVID-19 Risk

Upcoming Events

July

16

2024

1:00 PM - 2:30 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Deepali Kumar, MD, MSc, FRCP(C), FAST

Director
Ajmera Transplant Centre
University Health Network
Toronto, Canada

ProCE Banner Faculty
Erin K. McCreary, PharmD, BCIDP

Director of Infectious Diseases Improvement and Clinical Research Innovation
UPMC
Clinical Assistant Professor of Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania

ProCE Banner Faculty
Marcus Pereira, MD, MPH, FAST

Associate Professor of Medicine at CUIMC
Director of Clinical Services
Division of Infectious Diseases
Medical Director
Transplant Infectious Disease Program
Columbia University Irving Medical Center
New York, New York

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, confidence, and competence of learners in the use of anti-SARS-CoV-2 mAbs for solid organ transplant recipients.

Target Audience
This program is intended for transplant and infectious diseases specialists and other healthcare professionals who care for solid organ transplant recipients.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply expert guidance and recommendations for COVID-19 prophylaxis in transplant patients
  • Appropriately employ next-generation anti-SARS-CoV-2 monoclonal antibodies, when available, in at-risk transplant recipients
  • Formulate strategies to integrate COVID-19 mitigation into transplant management plans for high-risk transplant patients

Accreditation

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-105-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with ProCE, LLC

This program is supported by an educational grant from AstraZeneca.